amiodarone has been researched along with Depression in 4 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Depression: Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Presented is a case study of a seventy five year old man who experienced psychosis and depression related to the onset and termination of amiodarone therapy." | 7.76 | Psychosis and depression associated with alteration to amiodarone therapy. ( Cheesman, N; Taylor, D, 2010) |
| "Presented is a case study of a seventy five year old man who experienced psychosis and depression related to the onset and termination of amiodarone therapy." | 3.76 | Psychosis and depression associated with alteration to amiodarone therapy. ( Cheesman, N; Taylor, D, 2010) |
| "We compared results of five sensitive immunometric assays of serum thyrotropin (TSH) in controls and in different groups of patients with hyperthyroidism, untreated or treated; secondary hypothyroidism; nonthyroidal illness (NTI); or depression; or who were being treated with amiodarone." | 3.67 | Clinical significance of a low concentration of thyrotropin: five immunometric "kit" assays compared. ( Askienazy, S; Milhaud, G; Piketty, ML; Talbot, JN, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheesman, N | 1 |
| Taylor, D | 1 |
| DeVane, CL | 1 |
| Gill, HS | 1 |
| Markowitz, JS | 1 |
| Carson, WH | 1 |
| Odelola, AT | 1 |
| Piketty, ML | 1 |
| Talbot, JN | 1 |
| Askienazy, S | 1 |
| Milhaud, G | 1 |
4 other studies available for amiodarone and Depression
| Article | Year |
|---|---|
Psychosis and depression associated with alteration to amiodarone therapy.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Depression; Humans; Male; Psychoses, Substance-Induced; Su | 2010 |
Awareness of potential drug interactions may aid avoidance.
Topics: 1-Naphthylamine; Amiodarone; Anti-Arrhythmia Agents; Antidepressive Agents; Cytochrome P-450 CYP3A; | 1997 |
More on amiodarone-induced depression.
Topics: Amiodarone; Anti-Arrhythmia Agents; Depression; Humans; Hypothyroidism; Vasodilator Agents | 1999 |
Clinical significance of a low concentration of thyrotropin: five immunometric "kit" assays compared.
Topics: Adenoma; Adult; Amiodarone; Carbimazole; Depression; Female; Graves Disease; Humans; Hyperthyroidism | 1987 |